Who
Kristin Abate
Chief Accounting Officer
Company insider
Files Form 4 as: Chief Accounting Officer, Karyopharm Therapeutics.
In numbers
- Trades disclosed
- 25
- Buys
- 0
- Sells
- 12
- Bought
- $0
- Sold
- $25K
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 28 Feb 2025
- Last trade
- 16 Oct 2026
- Last filed
- 19 Oct 2026
Companies traded
Activity over time
1 Mar 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 16 Oct 2026filed 19 Oct 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,6474,788 at $0.344 | filing |
| 1 Oct 2026filed 2 Oct 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $450378 at $1.19 | filing |
| 1 Sep 2026filed 2 Sep 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $3819 at $2.02 | filing |
| 1 Sep 2026filed 2 Sep 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $3819 at $2.02 | filing |
| 14 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $50453 at $9.50 | filing |
| 14 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $50453 at $9.50 | filing |
| 13 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —121 at $0.00 | filing |
| 13 May 2026filed 15 May 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —121 at $0.00 | filing |
| 2 Mar 2026filed 3 Mar 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,260559 at $9.41 | filing |
| 2 Mar 2026filed 3 Mar 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $5,260559 at $9.41 | filing |
| 28 Jan 2026filed 29 Jan 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $35250 at $7.03 | filing |
| 28 Jan 2026filed 29 Jan 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $35250 at $7.03 | filing |
| 27 Jan 2026filed 29 Jan 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —92 at $0.00 | filing |
| 27 Jan 2026filed 29 Jan 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —92 at $0.00 | filing |
| 21 Jan 2026filed 22 Jan 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,579265 at $5.96 | filing |
| 21 Jan 2026filed 22 Jan 2026 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $1,579265 at $5.96 | filing |
| 15 Oct 2025filed 16 Oct 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —12,799 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $2,281362 at $6.30 | filing |
| 15 Sep 2025filed 16 Sep 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Sold | $14823 at $6.43 | filing |
| 12 Sep 2025filed 16 Sep 2025 | KPTI Karyopharm TherapeuticsBiotechnology | SEC FORM 4 Code A | —46 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.